NAUT

Nautilus Biotechnology, Inc.

2.90 USD

Last updated Dec 6, 03:38 UTC

Yesterday HIGH

$3.01

Yesterday LOW

$2.86

52w HIGH

$4.65

52w LOW

$1.5

EPS

-0.13

PE

-22.31

Next Earnings

Feb 22, 2024

Overview News Government Trades

Nautilus Biotechnology, Inc. stock is up 18.37% since 30 days ago. The next earnings date is Feb 22, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 December’s closed higher than November.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company was founded in 2016 and is headquartered in Seattle, Washington.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Measuring And Control Equipment

Headquarters

-

Website

nautilus.bio

Benzinga Insights

Mon Dec 19, 2022

Stocks That Hit 52-Week Lows On Monday

On Monday, 297 companies reached new 52-week lows.
Benzinga Insights

Fri Dec 16, 2022

Stocks That Hit 52-Week Lows On Friday

During Friday's trading, 293 companies set new 52-week lows.
Benzinga Insights

Tue Dec 13, 2022

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 49 companies hit new 52-week lows.
Benzinga Insights

Mon Dec 12, 2022

Stocks That Hit 52-Week Lows On Monday

Monday saw 196 companies set new 52-week lows.
Benzinga Insights

Thu Dec 8, 2022

Stocks That Hit 52-Week Lows On Thursday

During Thursday's trading, 138 companies set new 52-week lows.
Benzinga Insights

Tue Nov 22, 2022

Stocks That Hit 52-Week Lows On Tuesday

During Tuesday's trading, 160 companies set new 52-week lows.
Benzinga Insights

Tue Nov 1, 2022

Recap: Nautilus Biotechnology Q3 Earnings

Nautilus Biotechnology (NASDAQ:NAUT) reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:05 AM. Here's what investors need to know about the announcement.
Benzinga Newsdesk

Tue Nov 1, 2022

Nautilus Biotechnology Q3 EPS $(0.11) Beats $(0.15) Estimate

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 8.33 percent increase over losses of $(0.12) per share
Benzinga Insights

Tue Nov 1, 2022

Earnings Scheduled For November 1, 2022

Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion.
Benzinga Insights

Fri Sep 16, 2022

Stocks That Hit 52-Week Lows On Friday

During Friday's session, 574 stocks hit new 52-week lows.